Qsemble Capital Management’s Boston Scientific BSX Stock Holding History

Qsemble Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.26M	Sell	123,179 -102,688	-45%	-$5.58M	0.67%	40
2026 Q1	$14.2M	Buy	225,867 +97,901	+77%	+$7.83M	1.08%	2
2025 Q4	$12.2M	Buy	127,966 +50,313	+65%	+$4.93M	1.01%	6
2025 Q3	$7.58M	Buy	77,653 +57,242	+280%	+$5.93M	0.74%	35
2025 Q2	$2.19M	Sell	20,411 -7,152	-26%	-$724K	0.21%	150
2025 Q1	$2.78M	Buy	+27,563	New	+$2.78M	0.3%	124
2024 Q3	–	Sell	-34,926	Closed	-$2.69M	–	394
2024 Q2	$2.69M	Buy	+34,926	New	+$2.56M	0.51%	56
2023 Q3	–	Sell	-30,600	Closed	-$1.66M	–	328
2023 Q2	$1.66M	Buy	+30,600	New	+$1.6M	1.17%	11

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Qsemble Capital Management's BSX Position: Q2 2026 in Review

Qsemble Capital Management reduced its Boston Scientific (BSX) stake by 45% in Q2 2026, selling an estimated $5.58M and leaving 123,179 shares worth $5.26M. The position accounts for 0.67% of the portfolio, ranked #40.

Qsemble Capital Management first reported a position in BSX in Q2 2023 and has held it in 8 quarters since. The position peaked at $14.2M in Q1 2026. 1,476 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Qsemble Capital Management held 123,179 shares of Boston Scientific worth $5.26M as of Q2 2026.
Qsemble Capital Management sold 102,688 Boston Scientific shares in Q2 2026, an estimated $5.58M.
Boston Scientific made up 0.67% of Qsemble Capital Management's portfolio in Q2 2026, its #40 holding.
Qsemble Capital Management first reported a position in Boston Scientific in Q2 2023 and has held it in 8 quarters since.
Qsemble Capital Management's Boston Scientific position peaked at $14.2M in Q1 2026.
1,476 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.